Last Updated on January 6, 2024 by The Health Master
National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of fourteen (14) formulation under Drugs Prices Control Order (DPCO) – 2013 vide notification no. S. O. 2820 (E) dt 14-07-2021.
These formulations are as under:
| Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
| (1) | (2) | (3) | (4) | (5) | (6) |
| 1. | Dapagliflozin + Metformin Hydrochloride (As Extended release form) Tablet | Each film-coated bilayered tablet contains: Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin 5mg, Metformin Hydrochloride IP 1000mg (As Extended release form) | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd. | 7.54 |
| 2. | Dapagliflozin + Metformin Hydrochloride (As Extended release form) Tablet | Each film-coated bilayered tablet contains: Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin 10mg, Metformin Hydrochloride IP 1000mg (As Extended release form) | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd. | 11.30 |
| 3. | Dapagliflozin + Metformin Hydrochloride (As Extended release form) Tablet | Each film-coated bilayered tablet contains: Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin 10mg, Metformin Hydrochloride IP 500mg (As Extended release form) | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd. | 9.78 |
| 4. | Dapagliflozin + Metformin Hydrochloride (As Extended release form) Tablet | Each film-coated bilayered tablet contains: Dapagliflozin Propanediol monohydrate eq. to Dapagliflozin 5mg, Metformin Hydrochloride IP 500mg (As Extended release form) | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd. | 6.25 |
| 5. | Dapagliflozin + Metformin Hydrochloride Extended release Tablet | Each film-coated tablet contains: Dapagliflozin 10mg, Metformin Hydrochloride USP/IP 1000mg (As Extended release form) | 1 Tablet | M/s MSN Laboratories Pvt. Ltd. / M/s J. B. Chemicals & Pharmaceuticls Ltd. | 11.30 |
| 6. | Dapagliflozin + Metformin Hydrochloride Extended release Tablet | Each film-coated tablet contains: Dapagliflozin 10mg, Metformin Hydrochloride USP/IP 500mg (As Extended release form) | 1 Tablet | M/s MSN Laboratories Pvt. Ltd. / M/s J. B. Chemicals & Pharmaceuticls Ltd. | 9.78 |
| 7. | Dapagliflozin + Metformin Hydrochloride Extended release Tablet | Each film-coated tablet contains: Dapagliflozin 5mg, Metformin Hydrochloride USP/ IP 1000mg (As Extended release form) | 1 Tablet | M/s MSN Laboratories Pvt. Ltd. / M/s J. B. Chemicals & Pharmaceuticls Ltd. | 7.54 |
| 8. | Human Cogulation Factor IX Freeze Dried IP 1200IU | Each pack contains: Human Cogulation Factor IX Freeze Dried IP 1200IU Sterilized water for injection 10ml (EP/USP) | Each Pack | M/s Baxalta Bioscience India Pvt. Ltd. | 20996. 50 |
| 9. | Trastuzumab Lyophilized powder for | Combipack of A. Each multiple use vial contains: | Each Pack | M/s Intas Pharmaceuticals | 17500. 00 |
| Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
| (1) | (2) | (3) | (4) | (5) | (6) |
| concentrate for solution for infusion vial 375mg with Bacteriostatic water for injection USP 20ml vial | Trastuzumab 375mg B. Bacteriostatic water for injection USP 20ml vial | Limited | |||
| 10. | Saxagliptin + Metformin Hydrochloride (ER) Tablet | Each film coated tablet contains: Saxagliptin Hydrochloride eq. to Saxagliptin 2.5mg Metformin Hydrochloride IP 500mg (as extended Realease) | 1 Tablet | M/s Morepen Laboratories Limited | 17.70 |
| 11. | Saxagliptin + Metformin Hydrochloride (ER) Tablet | Each film coated tablet contains: Saxagliptin Hydrochloride eq. to Saxagliptin 2.5mg Metformin Hydrochloride IP 1000mg (as extended Realease) | 1 Tablet | M/s Morepen Laboratories Limited | 19.09 |
| 12. | Saxagliptin + Metformin Hydrochloride (ER) Tablet | Each film coated tablet contains: Saxagliptin Hydrochloride eq. to Saxagliptin 5mg Metformin Hydrochloride IP 500mg (as extended Realease) | 1 Tablet | M/s Morepen Laboratories Limited | 19.45 |
| 13. | Saxagliptin + Metformin Hydrochloride (ER) Tablet | Each film coated tablet contains: Saxagliptin Hydrochloride eq. to Saxagliptin 5mg Metformin Hydrochloride IP 1000mg (as extended Realease) | 1 Tablet | M/s Morepen Laboratories Limited | 20.84 |
| 14. | Ofloxacin +Metronidazole Tablet | Each film coated tablet contains: Ofloxacin USP 200mg Metronidazole IP 500mg | 1 Tablet | M/s Unique Pharmaceutical Laboratories (A division of M/s J. B. Chemicals & Pharmaceuticls Ltd) / M/s J. B. Chemicals & Pharmaceuticls Ltd. | 6.72 |
The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a Price List in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
As per para 24(4) of DPCO 2013, every retailer and dealer shall display Price List and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central / State Licensing Authority, as may be applicable, by the concerned manufacturer / marketing companies.
Latest Notifications: DPCO / NPPA
Latest Notifications: D&C Rules 1945
Latest Notifications: D&C Act 1940
In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
NPPA fixes retail prices of 11 formulations
NPPA fixes price of drug for the treatment of Black Fungus
NPPA exempts Torrent Pharma’s this drug from price regulation
NPPA: These three medicines are 50% costlier now
NPPA fixes retail prices of 3 formulations
NPPA fixes retail prices of 12 formulations
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
